Viral hepatitis vaccines.
Annu Rev Med
; 36: 241-61, 1985.
Article
em En
| MEDLINE
| ID: mdl-3922284
ABSTRACT
Purified from the plasma of hepatitis B carriers, hepatitis B surface antigen particles have been used in a vaccine to prevent hepatitis B. This plasma-derived vaccine is immunogenic, protective, and has an excellent safety record. Indications and strategies for preexposure and postexposure prophylaxis are reviewed. In addition, novel approaches to hepatitis B vaccine development are being pursued and will provide the basis for the next generation of vaccines. Early progress has also been made toward a hepatitis A vaccine, but clinical availability is not imminent.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Vacinas Virais
/
Vacinação
/
Hepatite B
/
Hepatite Viral Humana
Limite:
Adult
/
Child
/
Humans
/
Newborn
Idioma:
En
Revista:
Annu Rev Med
Ano de publicação:
1985
Tipo de documento:
Article